title: Enhanced CBir1-specific innate and adaptive immune responses in Crohn's disease.
abstract: BACKGROUND
  CBir1 is a dominant antigen with a role in innate and adaptive immunity in mouse models of colitis and antibodies to CBir1 are associated with severe human Crohn's disease (CD). Our aim was to determine whether CBir1 stimulates innate and antigen-specific T-cell responses in CD. We demonstrate that CBir1 enhanced IL-6 and IL-1beta production by peripheral blood (PB) monocytes.
  
  
  METHODS
  Real time polymerase chain reaction (PCR) was used for measurement of IL6 and IL1 expression. [(3)H] thymidine was used to measure T cell proliferation and Elispot assay was used to measure IFNgamma production.
  
  
  RESULTS
  IL-6 was significantly increased in monocytes from CD compared to controls and ulcerative colitis (UC). Anti-CBir1(+) patients and IL-6 was inversely correlated. A significant increase in CBir1-specific peripheral T-cell proliferation was more evident in cells from CD than controls and UC. CBir1 induced increased numbers of IFN-gamma(+) cells in lamina propria mononuclear cells (LPMC) from CD compared to UC and controls.
  
  
  CONCLUSIONS
  CBir1 induces enhanced peripheral innate and peripheral and mucosal antigen-specific T-cell responses in CD. Consistent with results from the mouse, CBir1 immune activation could play a role in CD.
authors.affiliation: Inflammatory Bowel Disease Research Center, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA.
authors.forename: Chong
authors.initials: C
authors.lastname: Shen
authors.forename: Carol J
authors.initials: CJ
authors.lastname: Landers
authors.forename: Carrie
authors.initials: C
authors.lastname: Derkowski
authors.forename: Charles O
authors.initials: CO
authors.lastname: Elson
authors.forename: Stephan R
authors.initials: SR
authors.lastname: Targan
mesh_terms: D001799:Blood Sedimentation; D002097:C-Reactive Protein / Q000378:metabolism; D016022:Case-Control Studies; D049109:Cell Proliferation; D002478:Cells, Cultured; D003093:Colitis, Ulcerative / Q000276:immunology / Q000473:pathology; D003106:Colon / Q000276:immunology; D003424:Crohn Disease / Q000276:immunology* / Q000473:pathology; D004797:Enzyme-Linked Immunosorbent Assay; D005408:Flagellin / Q000276:immunology*; D006801:Humans; D007113:Immunity, Innate; D007371:Interferon-gamma / Q000378:metabolism; D053583:Interleukin-1beta / Q000235:genetics / Q000378:metabolism; D015850:Interleukin-6 / Q000235:genetics / Q000378:metabolism; D007963:Leukocytes, Mononuclear / Q000276:immunology; D008213:Lymphocyte Activation / Q000276:immunology; D009000:Monocytes / Q000276:immunology*; D012333:RNA, Messenger / Q000378:metabolism; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: C502160:CBir1 flagellin; C508600:IL6 protein, human; D053583:Interleukin-1beta; D015850:Interleukin-6; D012333:RNA, Messenger; D011994:Recombinant Proteins; D005408:Flagellin; D007371:Interferon-gamma; D002097:C-Reactive Protein